Two federal developments have been on my mind this week.

On September 8, HHS announced $383.4 million in behavioral-health grants, with $252 million directed to 988, suicide prevention, and mobile crisis services.

At the same time, FDA is preparing a public discussion on the potential future therapeutic use of psychedelic drugs in supervised and supportive settings. The questions FDA is putting on the table include training, safety, informed consent, set and setting, follow-up, crisis coordination, privacy, interoperability, and longitudinal data.

I do not read either development as validation for my company.

I read them as a design challenge.

When care becomes a complex system, who is designing the experience of the human being moving through it?

That question sits at the center of my work.

The space between interactions matters

Healthcare and behavioral health are often discussed in terms of interventions, providers, facilities, treatments, technologies, and outcomes.

Those things matter.

But a person does not experience a system as an organizational chart.

A person experiences moments.

Where am I?

What happens next?

Who is responsible now?

What information am I being asked to provide?

Can I say no?

Can I pause?

Who do I contact when circumstances change?

Does the next person know what happened before?

Am I still making decisions — or has the system quietly started making them for me?

That space between interactions is easy to underestimate because it does not belong neatly to one department.

I call it the Human Layer.

Continuity is not the same as constant engagement

The 988 system offers a useful example.

A crisis contact can be a critical front door. But the experience cannot always end at the door.

SAMHSA’s 2026 work includes dedicated attention to crisis-center follow-up, coordination across crisis services, and connections to ongoing care and recovery resources.

That word — follow-up — contains an enormous design problem.

Good continuity is not about keeping someone continuously connected to a platform.

It is about making the next step understandable. It is about reducing avoidable fragmentation. It is about preserving a clear path back to qualified human support.

And it is about ensuring that technology does not become a substitute for the people, judgment, and accountability required in high-consequence situations.

Environment is part of the experience

FDA’s current psychedelic work makes another part of the Human Layer visible: environment.

The agency is asking about set and setting, patient education, informed consent, monitoring, post-administration follow-up, data practices, and coordination with emergency and crisis-response services.

I find that important even beyond the psychedelic context.

We often treat environment as background.

It is not.

The physical room, the digital interface, the language being used, the sensory conditions, the clarity of instructions, the presence or absence of a trusted human, and the ability to stop or ask for help all shape the experience of a consequential system.

This is one reason my own work has moved across software, immersive environments, music, interface design, governance, and operating systems.

I was never interested in technology by itself.

I was interested in the relationship between the technology and the person using it.

More capable technology requires clearer human boundaries

Artificial intelligence will make many systems more capable.

It will also make it easier to blur responsibility.

An intelligent system may be able to recommend, organize, personalize, detect patterns, generate language, or assist a professional.

But capability does not automatically confer authority.

The system may recommend. The human must remain able to understand, consent, decide, question, pause, and escalate.

In a high-consequence environment, there must also be clarity about when technology stops and an accountable qualified human takes over.

That principle is central to Cognitive State Design™:

Technology should adapt to humans — not require humans to adapt to technology.

What Cognitive State Systems is — and is not — trying to do

Cognitive State Systems™ is not being positioned as a clinical provider.

Clinical decisions, diagnosis, treatment, crisis response, and therapeutic responsibility remain with qualified providers.

Our work is focused on the human experience around the system: orientation, continuity, reflection, accessibility, participant control, human agency, data boundaries, and transparent interaction with intelligent tools.

The evidence boundary matters just as much.

A government funding announcement does not prove a CSS product.

An FDA hearing does not endorse our architecture.

Independent research can inform our design without certifying the result.

A pilot can establish usability or operational fit without proving a clinical outcome.

I believe we damage trust when we collapse those distinctions.

The right sequence is slower and stronger:

understand the problem → design a bounded experience → work with the right operators → measure what happens → improve → claim only what the evidence supports

Why I wrote The Human Layer

My new book, The Human Layer — Designing Human Agency in the Age of Intelligent Systems, is now available.

The book is broader than behavioral health.

It is about a question I believe every organization deploying increasingly capable technology will have to answer:

What should remain distinctly human when the system can do more?

Judgment. Consent. Purpose. Accountability. Dignity. The right to question the system. The right to remain a participant rather than become an object inside the workflow.

Behavioral health makes those questions especially visible because the stakes are human and immediate. But the design principle extends to leadership, education, work, consumer experiences, AI systems, and intelligent environments.

Read the idea. Then challenge what should be proved.

I also host small private founder briefings under The Human Layer — Founding 11, bringing together founders, operators, researchers, investors, and strategic partners to see what we have actually built, challenge the thesis, and help determine what is worth proving next.

The goal is not agreement.

The goal is a better question, a real operating problem, and — where the fit is genuine — a controlled working experience.

This article is educational and reflects my design perspective. It does not provide medical diagnosis, treatment, psychotherapy, crisis intervention, or clinical guidance.

Cognitive State Systems LLC develops evidence-governed human-experience systems designed around orientation, continuity, reflection, accessibility, participant control, and human agency. Clinical decisions and treatment remain with qualified providers.

If you or someone you know is in crisis in the United States, call or text 988 or use the 988 Lifeline chat service.

— Gil Cohen
Creator, Cognitive State Design™
Founder & Steward, Cognitive State Systems LLC

The public record behind this note